| Shirley W Chung, MD | |
|
147 Milk St, Obstetrics&gynecology Department, Boston, MA 02109-4806 | |
| (617) 654-7280 | |
| (617) 654-7363 |
| Full Name | Shirley W Chung |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 28 Years |
| Location | 147 Milk St, Boston, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174580823 | NPI | - | NPPES |
| G435 | Other | MA | HARVARD PILGRIM |
| 205602 | Other | MA | TUFTS HEALTH PLAN |
| 0020164 | Other | MA | NEIGHBORHOOD HEALTH PLAN |
| 8786893-001 | Other | MA | CIGNA |
| 0106381 | Medicaid | MA | |
| J22802 | Other | MA | BLUE CROSS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 205602 (Massachusetts) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Atrius Health Inc | 4789588641 | 1116 |
News Archive
Janssen Therapeutics, Division of Janssen Products, LP, announced today that the U.S. Food and Drug Administration (FDA) has approved a prescribing information update for EDURANT (rilpivirine) tablets to include 96-week pooled data from the Phase 3 ECHO and THRIVE studies, which evaluated the efficacy and safety of EDURANT for the treatment of human immunodeficiency virus type 1 (HIV-1) in antiretroviral treatment-naive adults.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that the European Medicines Agency has granted Orphan Drug Designation to AMT's gene therapy product AMT-080 for the treatment of Duchenne muscular dystrophy.
Medtronic plc today announced three-month results from a large, multicenter randomized controlled trial showing statistically significant (p=0.0009) and superior back pain relief with Differential Target Multiplexed (DTM) Spinal Cord Stimulation (SCS) compared to conventional SCS.
Scientists and surgeons at Princess Margaret Cancer Centre have discovered a promising new approach to treating colorectal cancer by disarming the gene that drives self-renewal in stem cells that are the root cause of disease, resistance to treatment and relapse. Colorectal cancer is the third leading cause of cancer-related death in the Western world.
Around one in 20 men is infertile, but despite the best efforts of scientists, in many cases the underlying causes of infertility have remained a mystery.
› Verified 1 days ago
| Entity Name | Atrius Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871639914 PECOS PAC ID: 4789588641 Enrollment ID: O20031121000582 |
News Archive
Janssen Therapeutics, Division of Janssen Products, LP, announced today that the U.S. Food and Drug Administration (FDA) has approved a prescribing information update for EDURANT (rilpivirine) tablets to include 96-week pooled data from the Phase 3 ECHO and THRIVE studies, which evaluated the efficacy and safety of EDURANT for the treatment of human immunodeficiency virus type 1 (HIV-1) in antiretroviral treatment-naive adults.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that the European Medicines Agency has granted Orphan Drug Designation to AMT's gene therapy product AMT-080 for the treatment of Duchenne muscular dystrophy.
Medtronic plc today announced three-month results from a large, multicenter randomized controlled trial showing statistically significant (p=0.0009) and superior back pain relief with Differential Target Multiplexed (DTM) Spinal Cord Stimulation (SCS) compared to conventional SCS.
Scientists and surgeons at Princess Margaret Cancer Centre have discovered a promising new approach to treating colorectal cancer by disarming the gene that drives self-renewal in stem cells that are the root cause of disease, resistance to treatment and relapse. Colorectal cancer is the third leading cause of cancer-related death in the Western world.
Around one in 20 men is infertile, but despite the best efforts of scientists, in many cases the underlying causes of infertility have remained a mystery.
› Verified 1 days ago
| Entity Name | Harvard Medical Faculty Phys At Beth Israel Deaconess Med Ctr Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518908136 PECOS PAC ID: 4486567104 Enrollment ID: O20031204000710 |
News Archive
Janssen Therapeutics, Division of Janssen Products, LP, announced today that the U.S. Food and Drug Administration (FDA) has approved a prescribing information update for EDURANT (rilpivirine) tablets to include 96-week pooled data from the Phase 3 ECHO and THRIVE studies, which evaluated the efficacy and safety of EDURANT for the treatment of human immunodeficiency virus type 1 (HIV-1) in antiretroviral treatment-naive adults.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that the European Medicines Agency has granted Orphan Drug Designation to AMT's gene therapy product AMT-080 for the treatment of Duchenne muscular dystrophy.
Medtronic plc today announced three-month results from a large, multicenter randomized controlled trial showing statistically significant (p=0.0009) and superior back pain relief with Differential Target Multiplexed (DTM) Spinal Cord Stimulation (SCS) compared to conventional SCS.
Scientists and surgeons at Princess Margaret Cancer Centre have discovered a promising new approach to treating colorectal cancer by disarming the gene that drives self-renewal in stem cells that are the root cause of disease, resistance to treatment and relapse. Colorectal cancer is the third leading cause of cancer-related death in the Western world.
Around one in 20 men is infertile, but despite the best efforts of scientists, in many cases the underlying causes of infertility have remained a mystery.
› Verified 1 days ago
| Entity Name | Beth Israel Deaconess Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548202641 PECOS PAC ID: 8123936119 Enrollment ID: O20041001000827 |
News Archive
Janssen Therapeutics, Division of Janssen Products, LP, announced today that the U.S. Food and Drug Administration (FDA) has approved a prescribing information update for EDURANT (rilpivirine) tablets to include 96-week pooled data from the Phase 3 ECHO and THRIVE studies, which evaluated the efficacy and safety of EDURANT for the treatment of human immunodeficiency virus type 1 (HIV-1) in antiretroviral treatment-naive adults.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that the European Medicines Agency has granted Orphan Drug Designation to AMT's gene therapy product AMT-080 for the treatment of Duchenne muscular dystrophy.
Medtronic plc today announced three-month results from a large, multicenter randomized controlled trial showing statistically significant (p=0.0009) and superior back pain relief with Differential Target Multiplexed (DTM) Spinal Cord Stimulation (SCS) compared to conventional SCS.
Scientists and surgeons at Princess Margaret Cancer Centre have discovered a promising new approach to treating colorectal cancer by disarming the gene that drives self-renewal in stem cells that are the root cause of disease, resistance to treatment and relapse. Colorectal cancer is the third leading cause of cancer-related death in the Western world.
Around one in 20 men is infertile, but despite the best efforts of scientists, in many cases the underlying causes of infertility have remained a mystery.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shirley W Chung, MD 147 Milk St, Boston, MA 02109-4806 Ph: (617) 654-7280 | Shirley W Chung, MD 147 Milk St, Obstetrics&gynecology Department, Boston, MA 02109-4806 Ph: (617) 654-7280 |
News Archive
Janssen Therapeutics, Division of Janssen Products, LP, announced today that the U.S. Food and Drug Administration (FDA) has approved a prescribing information update for EDURANT (rilpivirine) tablets to include 96-week pooled data from the Phase 3 ECHO and THRIVE studies, which evaluated the efficacy and safety of EDURANT for the treatment of human immunodeficiency virus type 1 (HIV-1) in antiretroviral treatment-naive adults.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that the European Medicines Agency has granted Orphan Drug Designation to AMT's gene therapy product AMT-080 for the treatment of Duchenne muscular dystrophy.
Medtronic plc today announced three-month results from a large, multicenter randomized controlled trial showing statistically significant (p=0.0009) and superior back pain relief with Differential Target Multiplexed (DTM) Spinal Cord Stimulation (SCS) compared to conventional SCS.
Scientists and surgeons at Princess Margaret Cancer Centre have discovered a promising new approach to treating colorectal cancer by disarming the gene that drives self-renewal in stem cells that are the root cause of disease, resistance to treatment and relapse. Colorectal cancer is the third leading cause of cancer-related death in the Western world.
Around one in 20 men is infertile, but despite the best efforts of scientists, in many cases the underlying causes of infertility have remained a mystery.
› Verified 1 days ago
Sheela S Maru, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 850 Harrison Ave, Yacc 4, Boston, MA 02118 Phone: 617-414-2000 Fax: 617-414-5798 | |
Dr. Devon Abt Harris, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 330 Brookline Ave # Shapiro8, Boston, MA 02215 Phone: 617-667-3736 Fax: 617-667-7493 | |
Maureen E Paul, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1055 Commonwealth Ave, Boston, MA 02215 Phone: 917-208-9521 | |
Charles-chidi W Obasiolu, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: Ctr For Fertility & Repro Hlth, 133 Brookline Ave, Boston, MA 02215 Phone: 617-421-2987 Fax: 617-421-2989 | |
Dr. Erik M Clinton, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 750 Washington St, Boston, MA 02111 Phone: 617-636-5000 | |
Evelyn Hall, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 800 Washington St, Boston, MA 02111 Phone: 269-552-8685 | |
Toni Beth Walzer, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 333 Longwood Avenue, Adolescent Gynecology, Boston, MA 02115 Phone: 617-355-5785 |